SCBIO is a clinical-stage biotechnology company dedicated to advancing innovative therapeutics for human health.
We focus on discovering and developing differentiated therapeutic assets that address significant unmet medical needs, with a strong emphasis on scientific rigor and translational value.

Our R&D strategy is asset-centric, building high-quality preclinical and clinical packages designed to maximize both medical impact and global development potential. SCBIO’s pipeline spans multiple modalities, including small-molecule therapeutics and next-generation antibody-drug conjugate (ADC) platforms, with a particular focus on immuno-oncology and immune-related diseases.

By integrating deep biological insight with advanced medicinal chemistry and translational research, SCBIO aims to efficiently progress programs from discovery through clinical readiness. We place strong emphasis on mechanism-driven innovation, robust data generation, and clear differentiation to support successful downstream development.

SCBIO operates with a global mindset, actively engaging with biopharmaceutical partners, academic collaborators, and research organizations worldwide. Our mission is to transform innovative science into meaningful therapeutic solutions that improve patient outcomes and contribute to the advancement of human health globally.

SCBIO Inc.

Org chart

Teams

Offices

SCBIO Inc.

Org chart

Teams

Offices

Related companies